| Name | Iofina |
|---|---|
| Epic | IOF |
| Isin | GB00B2QL5C79 |
| Industry | Chemicals |
| Latest share price | 19.00p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £36.45 | Debt ratio | n/a |
| Shares in issue | 191.86 | Debt-to-equity ratio | n/a |
| P/E ratio | 9.6 | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | 17.95 |
| Dividend cover | n/a | EPS growth | -17 |
| Earning per share | 3.4 | 52-week high / low | 17.50p / 28.80p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Iofina |
|---|---|
| Address | 48 Chancery Lane, London, United Kingdom, WC2A 1JF |
| Telephone | +44 (0)20 3006 3135 |
| Website | http://www.iofina.com |
| Director | Position |
|---|---|
| Mr William Bellamy("Bill") | Non-Executive Director |
| Mr Frank Mermoud | Non-Executive Director |
| Ms Mary Fallin | Non-Executive Director |
| Mr Lance J Baller | Non-Executive Chairman |
| Dr. Thomas M. Becker | President and CEO |
| Mr Malcolm Lewin | CFO & Executive Director |
| Assets $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 31/12/23 | 31/12/22 | 31/12/21 |
| Intangible asssets and goodwill | 3.19 | 3.37 | 3.55 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 28.38 | 26.11 | 26.73 |
| Inventory / work in progress | 10.14 | 10.18 | 6.3 |
| Trade and other receivables | 15.49 | 10.49 | 6.16 |
| Cash and equivalents | 6.52 | 5.93 | 5.26 |
| Other current assets and asset held for resale | n/a | n/a | n/a |
| Total of all assets | 60.52 | 52.71 | 44.45 |
| Liabilities $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 11.5 | 9.07 | 7.29 |
| Long term liabilities | 4.27 | 5.67 | 7.2 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 15.77 | 14.73 | 14.48 |
| Net assets $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 44.75 | 37.97 | 29.96 |
| Equity $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 3.11 | 3.11 | 3.11 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -15.47 | -22.03 | -29.9 |
| Share premium account | 60.69 | 60.69 | 60.69 |
| Total equity | 44.75 | 37.97 | 29.96 |
| Income $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | 8.6 | 9.64 | 5.21 |
| Pre-tax profit | 8.31 | 10.03 | 5.12 |